ESTRO 2024 - Abstract Book

S1967

Clinical - Mixed sites, palliation

ESTRO 2024

Conclusion:

Barriers for implementing a TwiCs approach within an international oncological registry trial have been identified and are currently being addressed in the E2R sub-project.

Keywords: oligometastases, trial design, SBRT

References:

[1] Alongi, F, Ricardi, U, Scorsetti, M, Liv, L, Balermpas, P, Lievens, Y, et al., “Cohort, OC -0269 Early toxicity of SBRT for oligometastatic cancer patients in the EORTC/ESTRO OligoCare,” Radiother. Oncol., vol. 182, no. S205, 2023, doi: 10.1016/S0167-8140(23)08564-X. [2] Kessels, R, May, AM, Koopman, M, and Roes, KCB, “The Trial within Cohorts (TwiCs) study design in oncology: experience and methodological reflections,” BMC Med. Res. Methodol., vol. 23, no. 1, 2023, doi: 10.1186/s12874 023-01941-5.

2265

Digital Poster

Clinical Implementation of a 0.35T MR-Linac in Spain: Initial Experience and Toxicity Assessment

Daniela Gonsalves 1,2 , Diego Rincon 1 , Abrahams Ocanto 1 , Lisselott Torres 1 , Miguel Montijano 1 , Castalia Fernandez 1 , Beatriz Sevilla 1 , Marina Amorin 3 , Marcos Guijarro 1 , José A Gonzales 4 , Jose Begara 5 , Eduardo Meilan 6 , Alberto Gomez 6 , David Esteban 7 , Sigfredo Romero 8 , Jesus Dominguez 9 , David Sanz 9 , Julia Rodriguez 9 , Alicia Sanchez 6 , Francisco Gongora 6 , Escarlata Lopez 1 , Felipe Couñago 1,2 1 GenesisCare, Radiation Oncology, Madrid, Spain. 2 Universidad Europea, Medicina, Madrid, Spain. 3 Hospital Braga, Radiation Oncology, Braga, Portugal. 4 GenesisCare, Radiation Oncology, Sevilla, Spain. 5 GenesisCare, Radiation Oncology, Malaga, Spain. 6 GenesisCare, Physics Deparment, Madrid, Spain. 7 GenesisCare, Radiation Oncology,